Like many of you, I grew up watching It’s a Wonderful Life on television every holiday season. Frank Capra’s beloved film was a comforting part of our holiday tradition, often playing in the ...

What if the tools you use every day could think, create, and collaborate with you like a trusted partner? With the arrival of Gemini 3, Google’s new AI model, this is no longer a futuristic fantasy, ...

DOWNERS GROVE, Ill., Nov. 18, 2025 /PRNewswire/ -- More than one million individuals worldwide have earned the CompTIA Security+ certification, CompTIA, the leading global provider of vendor-neutral ...

- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decrease from baseline in proteinuria in primary membranous nephropathy, and stabilization of estimated ...

The AirPods Pro 3 represent a blend of advanced technology and intuitive design, delivering a premium wireless audio experience. Whether you’re a first-time user or upgrading from a previous model, ...

The NFC West enters Week 3 with a combined record of 7-1. The Seattle Seahawks are the ones with the loss, and they enter a tricky contest against the New Orleans Saints this weekend. Although they ...

Lilly's orforglipron shows superior weight loss and blood sugar control Highest dose of the pill leads to 9.2% weight reduction Detailed trial results to be presented at future medical meeting The ...

People who consumed the highest levels of certain artificial sweeteners — equivalent to just one diet soda a day — saw a significant decline in their ability to remember and recall words when compared ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...